Rights and permissions
About this article
Cite this article
Which hepatitis C therapy worth it in IFN-α nonresponders?. Pharmacoecon. Outcomes News 410, 5 (2003). https://doi.org/10.1007/BF03276148
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03276148